Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has announced its participation in investor and analyst meetings. The company representatives will attend these meetings, which are scheduled to commence on June 9, 2026. The meetings will be held in person in Mumbai. A list of participating investors and analysts includes Alchemy Group, ASK Mutual, Bharti AXA Life Insurance, HSBC AM, JM Financial, Julius Baer, Lion Global (SG), Mahindra Manulife, Ninety One (LDN), Premji Invest, Samena, SBI MF, and Value Partners (HK). The company has noted that the schedule and mode of these meetings may be subject to change due to exigencies on the part of the investors, analysts, or the company itself. This disclosure is made pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
